Tag Archives: FDA

BIO Patient & Health Advocacy Summit: The Power of Partnerships

patient-summit-4

This week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to advance drug discovery by bringing together patient advocacy organizations, government agencies and industry leaders to discuss how to accelerate R&D, preserve patient access, leverage data and build collaborations focused on empowering patients. The rallying cry that reverberated throughout the event and over Twitter seemed clear from the beginning and Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals, Inc. captured it Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Gene Therapies Discussed at 2014 BIO Investor Forum

BIO Investor Forum

Since the great excitements and disappointments of gene therapy’s first clinical era, the 1990s, researchers have revised traditional approaches and developed innovative new techniques, including CRISPR/cas-9, to edit genes with greater speed and precision than ever before.  Across a wide range of diseases, gene therapy is showing traction with fresh clinical results and attracting more than $600 million in venture capital in the past two years.  However, real challenges remain in delivery of therapies in Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Cutting Through the Food Labeling Confusion

Food Labels

There was a lot of media buzz around a Consumer Reports study released yesterday that shows confusion around foods labeled “natural.” We agree that food labels can be confusing.  And that’s why we are part of a coalition of farm-to-fork organizations that support a federal legislative solution that will protect consumers by eliminating confusion around food labels while advancing food safety. In addition to requiring federal standards for companies that want to voluntarily label their Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , ,

New PhRMA report: Nearly 800 Cancer Medicines in Development

vaccines

A new report from the Pharmaceutical Research and Manufacturers of America (PhRMA) shows that biopharma companies are currently developing nearly 800 new medicines and vaccines for cancer. “In recent decades, we have seen great progress in developing effective cancer treatments that help extend lives, improve quality of life and increase productivity,” said PhRMA President and CEO John J. Castellani. “Continued research has expanded our knowledge of how cancer develops and how to target medicines for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Mito What???

Liz-Kennerly-115x76

Mitochondrial Disease: The Most Common Disease You’ve Probably Never Heard of… About 20 years ago, mitochondrial disease was virtually unheard of.  Just 10 years ago, it was considered rare. Today, according to NORD, a disease is considered rare when less than 200,000 people are affected.  Mitochondrial disease is not a single disease, but rather an entire umbrella of rare diseases.  For example, Alpers disease and Barth syndrome are very different and rare forms of mitochondrial Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,